Cargando…

Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms

The impact of coronavirus disease 2019 (COVID-19) pandemic on patients with neurodegenerative diseases and the specific neurological manifestations of COVID-19 have aroused great interest. However, there are still many issues of concern to be clarified. Therefore, we review the current literature on...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Pei, Zhang, Lin-Yuan, Tan, Yu-Yan, Chen, Sheng-Di
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885419/ https://www.ncbi.nlm.nih.gov/pubmed/36717892 http://dx.doi.org/10.1186/s40035-023-00337-1

Ejemplares similares

Correction: Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
por: Huang, Pei, et al.
Publicado: (2023)

Molecular Mechanisms Underlying Reciprocal Interactions Between Sleep Disorders and Parkinson’s Disease
por: Yang, Zhengjie, et al.
Publicado: (2021)

Neuroprotective Potential and Underlying Pharmacological Mechanism of Carvacrol for Alzheimer’s and Parkinson’s Diseases
por: Javed, Hayate, et al.
Publicado: (2023)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Shared Mechanisms of Neurodegeneration in Alzheimer's Disease and Parkinson's Disease
por: Xie, Anmu, et al.
Publicado: (2014)

Parkin as a Molecular Bridge Linking Alzheimer’s and Parkinson’s Diseases?
por: Checler, Frédéric, et al.
Publicado: (2022)

Cholesterol in the Pathogenesis of Alzheimer’s, Parkinson’s Diseases and Autism: Link to Synaptic Dysfunction
por: Petrov, A. M., et al.
Publicado: (2017)

Genetic insights into immune mechanisms of Alzheimer’s and Parkinson’s disease
por: Nott, Alexi, et al.
Publicado: (2023)

Key Disease Mechanisms Linked to Alzheimer’s Disease in the Entorhinal Cortex
por: Bottero, Virginie, et al.
Publicado: (2021)

Reciprocal impacts of obesity and coronavirus disease 2019
por: Heidari-Beni, Motahar, et al.
Publicado: (2020)

Medications Used for Cognitive Enhancement in Patients With Schizophrenia, Bipolar Disorder, Alzheimer’s Disease, and Parkinson’s Disease
por: Hsu, Wen-Yu, et al.
Publicado: (2018)

Mechanisms of Hybrid Oligomer Formation in the Pathogenesis of Combined Alzheimer's and Parkinson's Diseases
por: Tsigelny, Igor F., et al.
Publicado: (2008)

Medical Reciprocity
Publicado: (1899)

Medical Reciprocity
Publicado: (1903)

Mechanisms linking brain insulin resistance to Alzheimer's disease
por: Matioli, Maria Niures P.S., et al.
Publicado: (2015)

Pathological mechanisms and therapeutic strategies for Alzheimer’s disease
por: Ju, Yaojun, et al.
Publicado: (2021)

Compensation Strategies for Gait Impairments in Parkinson's Disease: From Underlying Mechanisms to Daily Clinical Practice
por: Tosserams, Anouk, et al.
Publicado: (2022)

Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease
por: Tsalenchuk, Maria, et al.
Publicado: (2023)

The reciprocal interactions between microglia and T cells in Parkinson’s disease: a double-edged sword
por: Xu, Yuxiang, et al.
Publicado: (2023)

Parkinson´s and Alzheimer´s Diseases and Natural Products: Pathologies and Medication of the New Times
por: Nabavi, Seyed Mohammad, et al.
Publicado: (2021)

Reciprocity: Different behavioural strategies, cognitive mechanisms and psychological processes
por: Schweinfurth, Manon K., et al.
Publicado: (2019)

Influence of Reciprocal Links in Social Networks
por: Zhu, Yu-Xiao, et al.
Publicado: (2014)

Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease
por: Hoekstra, Jake G, et al.
Publicado: (2011)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

Environmental Impact on the Epigenetic Mechanisms Underlying Parkinson’s Disease Pathogenesis: A Narrative Review
por: Angelopoulou, Efthalia, et al.
Publicado: (2022)

Cognitive interventions in Alzheimer's and Parkinson's diseases: emerging mechanisms and role of imaging
por: Vemuri, Prashanthi, et al.
Publicado: (2016)

Editorial: Molecular Mechanisms Involved in Heart Failure, Parkinson’s, and Alzheimer’s Diseases
por: Femminella, Grazia Daniela, et al.
Publicado: (2021)

Dissecting the limited genetic overlap of Parkinson's and Alzheimer's disease
por: Stolp Andersen, Maren, et al.
Publicado: (2022)

The Innate and Adaptive Immune Cells in Alzheimer's and Parkinson's Diseases
por: Huang, Boyuan, et al.
Publicado: (2022)

COVID-19 and digital inequalities: Reciprocal impacts and mitigation strategies
por: Beaunoyer, Elisabeth, et al.
Publicado: (2020)

Motivational and myopic mechanisms underlying dopamine medication-induced impulsive-compulsive behaviors in Parkinson's disease
por: Dawson, Andrew, et al.
Publicado: (2023)

Reciprocity in Medical Licensure
por: Vander Veer, Albert
Publicado: (1907)

Reciprocity in Medical Licensure
Publicado: (1897)

Reciprocity in Medical Licensure
Publicado: (1897)

Hypoxia and Alpha-Synuclein: Inextricable Link Underlying the Pathologic Progression of Parkinson's Disease
por: Guo, Mengyuan, et al.
Publicado: (2022)

Untangling the Tauopathy for Alzheimer’s disease and parkinsonism
por: Chang, Hui-Yun, et al.
Publicado: (2018)

Genetic networks in Parkinson’s and Alzheimer’s disease
por: Kelly, Jack, et al.
Publicado: (2020)

Alzheimer's and Parkinson's disease therapies in the clinic
por: Chopade, Puja, et al.
Publicado: (2022)

Editorial: Highlights in Alzheimer's and Parkinson's disease
por: Cantone, Mariagiovanna, et al.
Publicado: (2023)

Molecular and cellular mechanisms underlying the pathogenesis of Alzheimer’s disease
por: Guo, Tiantian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rcgc94qtngbjlh72es8u0haq48